Results 181 to 190 of about 1,471,936 (197)

A 2018–2019 patent review of metallo beta-lactamase inhibitors

Expert Opinion on Therapeutic Patents, 2020
Sooraj Baijnath, Mbongeni Shungube, Tricia Naicker   +2 more
exaly  

Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase

International Journal of Molecular Sciences, 2022
Roberto Carlos Pestana Nobles, Yani Aranguren, Daniel Kuroda   +2 more
exaly  

Development of sulfahydantoin derivatives as β-lactamase inhibitors

Bioorganic and Medicinal Chemistry Letters, 2021
Sophie Gobeil, Normand Voyer, Joelle Pelletier   +2 more
exaly  

Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain

International Journal of Antimicrobial Agents, 2023
Marta Martinez Guitian, Jorge Arca-Suárez, Alejandro Beceiro Casas   +2 more
exaly  

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians

Pharmaceuticals, 2022
Roberto Luzzati, Stefano di Bella, Giacomo Stroffolini   +2 more
exaly  

beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors

Expert Opinion on Investigational Drugs, 2000
David J Payne, J H Bateson
exaly  

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

Bioorganic and Medicinal Chemistry Letters, 2011
M R K Alley, Charles Z Ding, Jacob J Plattner   +2 more
exaly  

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update

Critical Reviews in Microbiology, 2009
Haris M Khan, P M Hawkey
exaly  

Synthesis and kinetic testing of new inhibitors for a metallo-β-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa

European Journal of Medicinal Chemistry, 2011
Waleed Hussein, Gerhard Schenk, Ross McGeary   +2 more
exaly  

β-Lactamase inhibitors: evolving compounds for evolving resistance targets

Expert Opinion on Investigational Drugs, 2004
Nafsika H Georgopapadakou
exaly